| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Yu,Jiu-Lu | Chairman | 14.05% | HENG TONG INTERNATIONAL INVESTMENT LTD. |
| Ma,Yong-Chang | Director | 14.05% | HENG TONG INTERNATIONAL INVESTMENT LTD. |
| Vacancy | Director | ||
| Wang,Wen-Xiong | Director | 14.05% | HENG TONG INTERNATIONAL INVESTMENT LTD. |
| Lin,Zhi-Kang | Director | 14.05% | HENG TONG INTERNATIONAL INVESTMENT LTD. |
| Yu,Feng-Rong | Supervisor | 0.00% |
Change Company Name to VIVOGEN PHARMACEUTICAL CO., LTD.
2024/05/07
Change Company Name to YUANSHI BIOTECH PHARMACEUTICAL CO., LTD. (FORMER NAME: YUNFENG BIOTECH PHARMACEUTICAL CO., LTD.)
2021/10/18
Change Company Name to VIVOGEN PHARMACEUTICAL CO., LTD.
2016/07/22
Change Person in Charge to Yu,Jiu-Lu
2014/09/25
Change Capital to 300,000,000
2013/04/15
Promissory note ruling
2020
Compensation for damage
2023
Determine legal expenses
2020, 2021
Allotment Objection Appeal
2021
Return deposit
2019
Stop execution
2020
Repay security deposit
2023
Compensation for damage
2016, 2017, 2018
Debtor objection appeal
2020, 2021, 2023
Allotment Objection Appeal
2022, 2023
Compensation for damage, etc.
2020
Request for damage compensation
2020
Retrial for damage compensation
2024
Request for damage compensation, etc.
2020
Retrial for damage compensation, etc.
2023, 2024
Violation of the Pharmaceutical Affairs Law, etc.
2023
Request for damage compensation, etc. petition for retrial
2020, 2021, 2024
